Global Virus Filtration Market Size study, By Product (Kits & Reagents, Systems, Services, Others), By Application (Biologicals, Medical Devices, Water Purification, Air Purification), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Medical Device Companies), and Regional Forecasts 2022-2028
Global Virus Filtration Market is valued approximately USD 3.65 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 12.3% over the forecast period 2022-2028.
Virus filtration is a method that is used to maintain a pathogen-free environment. The presence of various contagious agents such as microorganisms, viruses, bacteria, and others contaminate the water, air, and samples. Virus filtration is playing a vital role in the pharmaceutical industry make sure the purity and consumption of important items. This procedure proficiently maintains the hygiene of the laboratory. The increasing investment in the R&D activities by the leading companies, rising government support for the pharmaceutical & biotechnology sector, and flourishing growth of the biopharmaceutical industry are the major factors that are accelerating the market growth across the globe. For instance, as per Statista, in 2018, the biopharmaceutical industry was recorded with total revenue of USD 5.28 trillion. Also, the industry witnesses an upsurge and reached USD 7.15 trillion in January 2021. Thereby, the growth of the biopharmaceutical sector is augmenting the demand for virus filtration in the near future. However, stringent regulations for the validation of filtration products and a highly consolidated market impede the growth of the market over the forecast period of 2022-2028. In addition, increasing pharmaceutical outsourcing and the rising adoption of single-use technologies are anticipated to act as catalyzing factors for the market demand during the forecast period.
The key regions considered for the global Virus Filtration market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growth of the biopharmaceutical industry and the presence of the leading market players in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing incidences of infectious diseases, as well as the development of emerging economies such as India and China, would create lucrative growth prospects for the Virus Filtration market across the Asia-Pacific region.
Major market players included in this report are:
Merck & Co., Inc.
General Electric Company
Thermo Fisher Scientific Inc.
Lonza Group Ltd.
Pall Corporation
Charles River Laboratories International, Inc.
Sigma-Aldrich Corporation
Sartorius AG
Asahi Kasei Medical Co., Ltd.
WuXi PharmaTech (Cayman) Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Kits & Reagents
Systems
Services
Others
By Application
Biologicals
Medical Devices
Water Purification
Air Purification
By End User
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Medical Device Companies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Virus Filtration Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
Merck & Co., Inc.
General Electric Company
Thermo Fisher Scientific Inc.
Lonza Group Ltd.
Pall Corporation
Charles River Laboratories International, Inc.
Sigma-Aldrich Corporation
Sartorius AG
Asahi Kasei Medical Co., Ltd.
WuXi PharmaTech (actions.Cayman) Inc.
Please note: The single user license is non-downloadable and non-printable. Global Site license allows these.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook